Biodiem Limited ASX: BDM - Completes Treatment Phase I And II Study Of Eye Drug - Mr Tom Williams, MD

Sydney, Aug 13, 2007 (ABN Newswire) - Biodiem Limited (ASX: BDM) - Completes Treatment Phase I and II Study of Eye Drug - Mr Tom Williams, MD; Biodiem Limited (ASX: BDM) present the following audio webcast regarding "Completes Treatment Phase I and II Study of Eye Drug". You may also download this audio webcast to your computer or portable audio player.

Broadcaster: Biodiem Limited (ASX: BDM)

Broadcast Title: Completes Treatment Phase I and II Study of Eye Drug

Broadcast Type: Audio stream

Audio webcast Link:

http://acnnewswire.net/alnk/5F72R5ZF

Listen to the Audio stream and view the announcement for Biodiem Limited (ASX: BDM) below.

http://abnnewswire.net/vlnk/E0J7XRSN


This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.

Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.